A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue

NCT07248020 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
Locally Advanced Rectal Cancer
Radiation-Induced Enteritis
Radiation Proctitis
Chemoradiotherapy-Related Toxicity

Interventions

DIETARY_SUPPLEMENT: Curcumin (BCM-95®)

Sponsor

Chang Gung Memorial Hospital